G. K. Wenning, F. Geser, and F. Krismer, The natural history of multiple system atrophy: a prospective European cohort study, Lancet Neurol, vol.12, pp.264-274, 2013.

A. Schrag, Y. Ben-shlomo, and N. P. Quinn, Prevalence of progressive supranuclear palsy and multiple system atrophy: a cross-sectional study, Lancet, vol.354, pp.1771-1775, 1999.

F. Tison, F. Yekhlef, V. Chrysostome, and C. Sourgen, Prevalence of multiple system atrophy, Lancet, vol.355, pp.495-496, 2000.

S. W. Schwarzacher, U. Rub, and T. Deller, Neuroanatomical characteristics of the human pre-Botzinger complex and its involvement in neurodegenerative brainstem diseases, Brain, vol.134, pp.24-35, 2011.

M. Tada, A. Kakita, and Y. Toyoshima, Depletion of medullary serotonergic neurons in patients with multiple system atrophy who succumbed to sudden death, Brain, vol.132, pp.1810-1819, 2009.

M. G. Spillantini and M. Goedert, The alpha-synucleinopathies: Parkinson's disease, dementia with Lewy bodies, and multiple system atrophy, Ann N Y Acad Sci, vol.920, pp.16-27, 2000.

M. D. Cykowski, E. A. Coon, and S. Z. Powell, Expanding the spectrum of neuronal pathology in multiple system atrophy, Brain, vol.138, pp.2293-2309, 2015.

P. J. Kahle, M. Neumann, and L. Ozmen, Hyperphosphorylation and insolubility of alpha-synuclein in transgenic mouse oligodendrocytes, EMBO Rep, vol.3, pp.583-588, 2002.

I. Yazawa, B. I. Giasson, and R. Sasaki, Mouse model of multiple system atrophy alpha-synuclein expression in oligodendrocytes causes glial and neuronal degeneration, Neuron, vol.45, pp.847-859, 2005.

C. W. Shults, E. Rockenstein, and L. Crews, Neurological and neurodegenerative alterations in a transgenic mouse model expressing human alpha-synuclein under oligodendrocyte promoter: implications for multiple system atrophy, J Neurosci, vol.25, pp.10689-10699, 2005.

P. O. Fernagut and F. Tison, Animal models of multiple system atrophy, Neuroscience, vol.211, pp.77-82, 2012.

A. Ulusoy, M. Decressac, D. Kirik, and A. Bjorklund, Viral vectormediated overexpression of alpha-synuclein as a progressive model of Parkinson's disease, Prog Brain Res, vol.184, pp.89-111, 2010.

B. Dehay, D. Dalkara, S. Dovero, Q. Li, and E. Bezard, Systemic scAAV9 variant mediates brain transduction in newborn rhesus macaques, Sci Rep, vol.2, p.253, 2012.
URL : https://hal.archives-ouvertes.fr/hal-01053467

G. Von-jonquieres, N. Mersmann, and C. B. Klugmann, Glial promoter selectivity following AAV-delivery to the immature brain, PLoS One, vol.8, p.65646, 2013.

M. Decressac, B. Mattsson, M. Lundblad, P. Weikop, and A. Bjorklund, Progressive neurodegenerative and behavioural changes induced by AAV-mediated overexpression of alpha-synuclein in midbrain dopamine neurons, Neurobiol Dis, vol.45, pp.939-953, 2012.

T. Nonaka and M. Hasegawa, A cellular model to monitor proteasome dysfunction by alpha-synuclein, Biochemistry, vol.48, pp.8014-8022, 2009.

C. Mcclure, K. L. Cole, P. Wulff, M. Klugmann, and A. J. Murray, Production and titering of recombinant adeno-associated viral vectors, J Vis Exp, issue.57, p.3348, 2011.

W. Xiao, N. Chirmule, S. C. Berta, B. Mccullough, G. Gao et al., Gene therapy vectors based on adeno-associated virus type 1, J Virol, vol.73, pp.3994-4003, 1999.

S. Zolotukhin, B. J. Byrne, and E. Mason, Recombinant adenoassociated virus purification using novel methods improves infectious titer and yield, Gene Ther, vol.6, pp.973-985, 1999.

C. Aurnhammer, M. Haase, and N. Muether, Universal real-time PCR for the detection and quantification of adeno-associated virus serotype 2-derived inverted terminal repeat sequences, Hum Gene Ther Methods, vol.23, pp.18-28, 2012.

M. Engeln, M. F. Bastide, and . Toulm-e-e, Selective inactivation of striatal fosb/deltafosb-expressing neurons alleviates L-DOPA-Induced dyskinesia, Biol Psychiatry, vol.79, pp.354-361, 2016.

G. Porras, A. Berthet, and B. Dehay, PSD-95 expression controls L-DOPA dyskinesia through dopamine D1 receptor trafficking, J Clin Invest, vol.122, pp.3977-3989, 2012.
URL : https://hal.archives-ouvertes.fr/hal-00956903

N. M. Urs, S. Bido, and S. M. Peterson, Targeting beta-arrestin2 in the treatment of L-DOPA-induced dyskinesia in Parkinson's disease, Proc Natl Acad Sci U S A, vol.112, pp.2517-2526, 2015.

M. Engeln, S. Fasano, and S. H. Ahmed, Levodopa gains psychostimulant-like properties after nigral dopaminergic loss, Ann Neurol, vol.74, pp.140-144, 2013.
URL : https://hal.archives-ouvertes.fr/hal-01153692

E. Abati, A. Di-fonzo, and S. Corti, In vitro models of multiple system atrophy from primary cells to induced pluripotent stem cells, J Cell Mol Med, vol.22, pp.2536-2546, 2018.

V. B. Adams-r and . Van-der-eecken-h, Dégénérescences nigro-striées et cerebello-nigrostriées, 1961.

M. B. Aerts, R. A. Esselink, W. F. Abdo, B. R. Bloem, and M. M. Verbeek, CSF alphasynuclein does not differentiate between parkinsonian disorders, Neurobiol Aging, vol.33, pp.1-3, 2012.

Z. Ahmed, Y. T. Asi, A. Sailer, A. J. Lees, H. Houlden et al., The neuropathology, pathophysiology and genetics of multiple system atrophy, Neuropathol Appl Neurobiol, vol.38, pp.4-24, 2012.

B. H. Ahn, H. Rhim, S. Y. Kim, Y. M. Sung, M. Y. Lee et al., alpha-Synuclein interacts with phospholipase D isozymes and inhibits pervanadateinduced phospholipase D activation in human embryonic kidney-293 cells, J Biol Chem, vol.277, pp.12334-12376, 2002.

K. Albert, M. H. Voutilainen, A. Domanskyi, and M. Airavaara, AAV Vector-Mediated Gene Delivery to Substantia Nigra Dopamine Neurons: Implications for Gene Therapy and Disease Models, Genes, vol.8, 2017.

A. I. Amaral, J. M. Tavares, U. Sonnewald, and M. R. Kotter, Oligodendrocytes: Development, Physiology and Glucose Metabolism, Adv Neurobiol, vol.13, pp.275-294, 2016.

K. Arai, N. Kato, K. Kashiwado, and T. Hattori, Pure autonomic failure in association with human alpha-synucleinopathy, Neurosci Lett, vol.296, pp.171-174, 2000.

R. A. Armstrong, N. J. Cairns, and P. L. Lantos, Multiple system atrophy (MSA): topographic distribution of the alpha-synuclein-associated pathological changes, Parkinsonism Relat Disord, vol.12, pp.356-62, 2006.

R. Ashour, R. Tintner, and J. Jankovic, Striatal deformities of the hand and foot in Parkinson's disease, Lancet Neurol, vol.4, pp.423-454, 2005.

Y. T. Asi, J. E. Simpson, P. R. Heath, S. B. Wharton, A. J. Lees et al., Alpha-synuclein mRNA expression in oligodendrocytes in MSA, Glia, vol.62, pp.964-70, 2014.

N. Auzou, K. Dujardin, R. Biundo, A. Foubert-samier, C. Barth et al., Diagnosing dementia in multiple system atrophy by applying Movement Disorder Society diagnostic criteria for Parkinson's disease dementia, Parkinsonism Relat Disord, vol.21, pp.1273-1280, 2015.

M. Bacioglu, L. F. Maia, O. Preische, J. Schelle, A. Apel et al., Neurofilament Light Chain in Blood and CSF as Marker of Disease Progression in Mouse Models and in Neurodegenerative Diseases, Neuron, vol.91, pp.56-66, 2016.

W. A. Banks, J. B. Jaspan, W. Huang, and A. J. Kastin, Transport of insulin across the bloodbrain barrier: saturability at euglycemic doses of insulin, Peptides, vol.18, pp.1423-1432, 1997.

M. J. Baptista, C. O'farrell, S. Daya, R. Ahmad, D. W. Miller et al., Co-ordinate transcriptional regulation of dopamine synthesis genes by alpha-synuclein in human neuroblastoma cell lines, J Neurochem, vol.85, pp.957-68, 2003.

R. Barbour, K. Kling, J. P. Anderson, K. Banducci, T. Cole et al., Red blood cells are the major source of alpha-synuclein in blood, Neurodegener Dis, vol.5, pp.55-64, 2008.

F. Bassil, M. H. Canron, A. Vital, E. Bezard, Y. Li et al., Insulin resistance and exendin-4 treatment for multiple system atrophy, Brain, vol.140, pp.1420-1436, 2017.
URL : https://hal.archives-ouvertes.fr/hal-01537233

F. Bassil, P. O. Fernagut, E. Bezard, and W. G. Meissner, Insulin, IGF-1 and GLP-1 signaling in neurodegenerative disorders: targets for disease modification, Prog Neurobiol, vol.118, pp.1-18, 2014.
URL : https://hal.archives-ouvertes.fr/hal-01289729

F. Bassil, P. O. Fernagut, E. Bezard, A. Pruvost, T. Leste-lasserre et al., Reducing C-terminal truncation mitigates synucleinopathy and neurodegeneration in a transgenic model of multiple system atrophy, Proc Natl Acad Sci U S A, vol.113, pp.9593-9601, 2016.
URL : https://hal.archives-ouvertes.fr/hal-01370967

E. E. Benarroch, A. M. Schmeichel, P. A. Low, and J. E. Parisi, Differential involvement of the periaqueductal gray in multiple system atrophy, Auton Neurosci, vol.158, pp.111-118, 2010.

E. E. Benarroch, A. M. Schmeichel, P. Sandroni, P. A. Low, and J. E. Parisi, Differential involvement of hypothalamic vasopressin neurons in multiple system atrophy, Brain, vol.129, pp.2688-96, 2006.

E. E. Benarroch, A. M. Schmeichel, P. Sandroni, P. A. Low, and J. E. Parisi, Involvement of vagal autonomic nuclei in multiple system atrophy and Lewy body disease, Neurology, vol.66, pp.378-83, 2006.

E. E. Benarroch, I. L. Smithson, P. A. Low, and J. E. Parisi, Depletion of catecholaminergic neurons of the rostral ventrolateral medulla in multiple systems atrophy with autonomic failure, Ann Neurol, vol.43, pp.156-63, 1998.

I. Benatru, M. Vaugoyeau, and J. P. Azulay, Postural disorders in Parkinson's disease, Neurophysiol Clin, vol.38, pp.459-65, 2008.

A. Berardelli, J. C. Rothwell, P. D. Thompson, and M. Hallett, Pathophysiology of bradykinesia in Parkinson's disease, vol.124, pp.2131-2177, 2001.

A. Bjornsdottir, G. Gudmundsson, H. Blondal, and E. Olafsson, Incidence and prevalence of multiple system atrophy: a nationwide study in Iceland, J Neurol Neurosurg Psychiatry, vol.84, pp.136-176, 2013.

J. M. Bleasel, J. H. Wong, G. M. Halliday, and W. S. Kim, Lipid dysfunction and pathogenesis of multiple system atrophy, Acta Neuropathol Commun, vol.2, p.15, 2014.

M. Boudes, P. Uvin, S. Pinto, T. Voets, C. J. Fowler et al., Bladder dysfunction in a transgenic mouse model of multiple system atrophy, Mov Disord, vol.28, pp.347-55, 2013.

M. Bourdenx and B. Dehay, What lysosomes actually tell us about Parkinson's disease?, Ageing Res Rev, vol.32, pp.140-149, 2016.
URL : https://hal.archives-ouvertes.fr/inserm-02439406

J. Bove, M. Martinez-vicente, and M. Vila, Fighting neurodegeneration with rapamycin: mechanistic insights, Nat Rev Neurosci, vol.12, pp.437-52, 2011.

J. H. Bower, D. M. Maraganore, S. K. Mcdonnell, and W. A. Rocca, Incidence of progressive supranuclear palsy and multiple system atrophy in Olmsted County, Neurology, vol.49, pp.1284-1292, 1976.

S. Brahmachari, P. Ge, S. H. Lee, D. Kim, S. S. Karuppagounder et al., Activation of tyrosine kinase c-Abl contributes to alpha-synuclein-induced neurodegeneration, J Clin Invest, vol.126, pp.2970-88, 2016.

C. Brenneis, S. M. Boesch, K. E. Egger, K. Seppi, C. Scherfler et al., Cortical atrophy in the cerebellar variant of multiple system atrophy: a voxel-based morphometry study, Mov Disord, vol.21, pp.159-65, 2006.

T. Brudek, K. Winge, N. B. Rasmussen, J. M. Bahl, J. Tanassi et al., Altered alpha-synuclein, parkin, and synphilin isoform levels in multiple system atrophy brains, J Neurochem, vol.136, pp.172-85, 2016.

S. Bukhatwa, B. Y. Zeng, S. Rose, and P. Jenner, A comparison of changes in proteasomal subunit expression in the substantia nigra in Parkinson's disease, multiple system atrophy and progressive supranuclear palsy, Brain Res, vol.1326, pp.174-83, 2010.

J. Burre, The Synaptic Function of alpha-Synuclein, J Parkinsons Dis, vol.5, pp.699-713, 2015.

J. Burre, M. Sharma, T. Tsetsenis, V. Buchman, M. R. Etherton et al., Alpha-synuclein promotes SNARE-complex assembly in vivo and in vitro, Science, vol.329, pp.1663-1670, 2010.

B. Butler, S. Goodwin, K. Saha, J. Becker, D. Sambo et al., Dopamine Transporter Activity Is Modulated by alpha-synuclein, J Biol Chem, 2015.

S. Chandra, F. Fornai, H. B. Kwon, U. Yazdani, D. Atasoy et al., Double-knockout mice for alphaand beta-synucleins: effect on synaptic functions, Proc Natl Acad Sci U S A, vol.101, pp.14966-71, 2004.

R. H. Chen, S. Wislet-gendebien, F. Samuel, N. P. Visanji, G. Zhang et al., alpha-Synuclein membrane association is regulated by the Rab3a recycling machinery and presynaptic activity, J Biol Chem, vol.288, pp.7438-7487, 2013.

S. L. Chiu and H. T. Cline, Insulin receptor signaling in the development of neuronal structure and function, Neural Dev, vol.5, p.7, 2010.

V. Chrysostome, F. Tison, F. Yekhlef, C. Sourgen, I. Baldi et al., Epidemiology of multiple system atrophy: a prevalence and pilot risk factor study in, Neuroepidemiology, vol.23, pp.201-209, 2004.

M. Ciccarelli, J. K. Chuprun, G. Rengo, E. Gao, Z. Wei et al., G protein-coupled receptor kinase 2 activity impairs cardiac glucose uptake and promotes insulin resistance after myocardial ischemia, Circulation, vol.123, pp.1953-62, 2011.

C. Colosimo, Nonmotor presentations of multiple system atrophy, Nat Rev Neurol, vol.7, pp.295-303, 2011.

R. Constantinescu, L. Rosengren, B. Johnels, H. Zetterberg, and B. Holmberg, Consecutive analyses of cerebrospinal fluid axonal and glial markers in Parkinson's disease and atypical Parkinsonian disorders, Parkinsonism Relat Disord, vol.16, pp.142-147, 2010.

E. A. Coon, R. D. Fealey, D. M. Sletten, J. N. Mandrekar, E. E. Benarroch et al., Anhidrosis in multiple system atrophy involves pre-and postganglionic sudomotor dysfunction, Mov Disord, vol.32, pp.397-404, 2017.

N. Cremades, S. I. Cohen, E. Deas, A. Y. Abramov, A. Y. Chen et al., Direct observation of the interconversion of normal and toxic forms of alpha-synuclein, Cell, vol.149, pp.1048-59, 2012.

L. Crews, B. Spencer, P. Desplats, C. Patrick, A. Paulino et al., Selective molecular alterations in the autophagy pathway in patients with Lewy body disease and in models of alphasynucleinopathy, PLoS One, vol.5, p.9313, 2010.

A. J. Da-rocha, A. C. Maia, . Jr, . Da, C. J. Silva et al., Pyramidal tract degeneration in multiple system atrophy: the relevance of magnetization transfer imaging, Mov Disord, vol.22, pp.238-282, 2007.

W. Dauer and S. Przedborski, Parkinson's disease: mechanisms and models, Neuron, vol.39, pp.889-909, 2003.

B. Dehay, M. Bourdenx, P. Gorry, S. Przedborski, M. Vila et al., Targeting alpha-synuclein for treatment of Parkinson's disease: mechanistic and therapeutic considerations, Lancet Neurol, vol.14, pp.855-866, 2015.

B. Dehay, J. Bove, N. Rodriguez-muela, C. Perier, A. Recasens et al., Pathogenic lysosomal depletion in Parkinson's disease, J Neurosci, vol.30, pp.12535-12579, 2010.

B. Dehay and P. O. Fernagut, Alpha-synuclein-based models of Parkinson's disease, Rev Neurol, vol.172, pp.371-379, 2016.

B. Dehay, M. Martinez-vicente, G. A. Caldwell, K. A. Caldwell, Z. Yue et al., Lysosomal impairment in Parkinson's disease, vol.28, pp.725-757, 2013.

T. A. Dejerine-j, L'atrophie olivo-ponto-cérébelleuse, pp.424-427, 1900.

D. L. Deremer, C. Ustun, and K. Natarajan, Nilotinib: a second-generation tyrosine kinase inhibitor for the treatment of chronic myelogenous leukemia, Clin Ther, vol.30, pp.1956-75, 2008.

P. Desplats, H. J. Lee, E. J. Bae, C. Patrick, E. Rockenstein et al., Inclusion formation and neuronal cell death through neuron-to-neuron transmission of alpha-synuclein, Proc Natl Acad Sci U S A, vol.106, pp.13010-13015, 2009.

S. M. Dewire, S. Ahn, R. J. Lefkowitz, and S. K. Shenoy, Beta-arrestins and cell signaling, Annu Rev Physiol, vol.69, pp.483-510, 2007.

M. Djelloul, S. Holmqvist, A. Boza-serrano, C. Azevedo, M. S. Yeung et al., Alpha-Synuclein Expression in the Oligodendrocyte Lineage: an In Vitro and In Vivo Study Using Rodent and Human Models, Stem Cell Reports, vol.5, pp.174-84, 2015.

A. S. Don, J. H. Hsiao, J. M. Bleasel, T. A. Couttas, G. M. Halliday et al., Altered lipid levels provide evidence for myelin dysfunction in multiple system atrophy, Acta Neuropathol Commun, vol.2, p.150, 2014.

L. Dotevall, L. E. Rosengren, and L. Hagberg, Increased cerebrospinal fluid levels of glial fibrillary acidic protein (GFAp) in Lyme neuroborreliosis, Infection, vol.24, pp.125-134, 1996.

J. T. Dou, M. Chen, F. Dufour, D. L. Alkon, and W. Q. Zhao, Insulin receptor signaling in long-term memory consolidation following spatial learning, Learn Mem, vol.12, pp.646-55, 2005.

D. Ebrahimi-fakhari, L. Wahlster, and P. J. Mclean, Protein degradation pathways in Parkinson's disease: curse or blessing, Acta Neuropathol, vol.124, pp.153-72, 2012.

F. N. Emamzadeh, Alpha-synuclein structure, functions, and interactions, J Res Med Sci, vol.21, p.29, 2016.

B. Ettle, S. Reiprich, J. Deusser, J. C. Schlachetzki, W. Xiang et al., Intracellular alpha-synuclein affects early maturation of primary oligodendrocyte progenitor cells, Mol Cell Neurosci, vol.62, pp.68-78, 2014.

A. Fanciulli and G. K. Wenning, Multiple-system atrophy, N Engl J Med, vol.372, pp.1375-1381, 2015.

L. Fellner, K. A. Jellinger, G. K. Wenning, and N. Stefanova, Glial dysfunction in the pathogenesis of alpha-synucleinopathies: emerging concepts, Acta Neuropathol, vol.121, pp.675-93, 2011.

L. Ferini-strambi and S. Marelli, Sleep dysfunction in multiple system atrophy, Curr Treat Options Neurol, vol.14, pp.464-73, 2012.

P. O. Fernagut, W. G. Meissner, M. Biran, M. Fantin, F. Bassil et al., Age-related motor dysfunction and neuropathology in a transgenic mouse model of multiple system atrophy, Synapse, vol.68, pp.98-106, 2014.

P. O. Fernagut and F. Tison, Animal models of multiple system atrophy, Neuroscience, vol.211, pp.77-82, 2012.

O. Flabeau, W. G. Meissner, A. Ozier, P. Berger, F. Tison et al., Breathing variability and brainstem serotonergic loss in a genetic model of multiple system atrophy, Mov Disord, vol.29, pp.388-95, 2014.

S. M. Fleming, O. R. Ekhator, and V. Ghisays, Assessment of sensorimotor function in mouse models of Parkinson's disease, J Vis Exp, 2013.

W. C. Fok, Y. Chen, A. Bokov, Y. Zhang, A. B. Salmon et al., Mice fed rapamycin have an increase in lifespan associated with major changes in the liver transcriptome, J Clin Invest, vol.9, pp.65-74, 2014.

H. Fujishiro, T. B. Ahn, R. Frigerio, A. Delledonne, K. A. Josephs et al., Glial cytoplasmic inclusions in neurologically normal elderly: prodromal multiple system atrophy?, Acta Neuropathol, vol.116, pp.269-75, 2008.

H. Fujiwara, M. Hasegawa, N. Dohmae, A. Kawashima, E. Masliah et al., alpha-Synuclein is phosphorylated in synucleinopathy lesions, Nat Cell Biol, vol.4, pp.160-164, 2002.

Y. Furukawa, S. Vigouroux, H. Wong, M. Guttman, A. H. Rajput et al., Brain proteasomal function in sporadic Parkinson's disease and related disorders, Ann Neurol, vol.51, pp.779-82, 2002.

W. P. Gai, D. L. Pountney, J. H. Power, Q. X. Li, J. G. Culvenor et al., alpha-Synuclein fibrils constitute the central core of oligodendroglial inclusion filaments in multiple system atrophy, Exp Neurol, vol.181, pp.68-78, 2003.

J. E. Galvin, V. M. Lee, and J. Q. Trojanowski, Synucleinopathies: clinical and pathological implications, Arch Neurol, vol.58, pp.186-90, 2001.

S. Gilman, S. J. May, C. W. Shults, C. M. Tanner, W. Kukull et al., The North American Multiple System Atrophy Study Group, J Neural Transm, vol.112, pp.1687-94, 2005.

S. Gilman, G. K. Wenning, P. A. Low, D. J. Brooks, C. J. Mathias et al., Second consensus statement on the diagnosis of multiple system atrophy, vol.71, pp.670-676, 2008.

D. S. Goldstein, C. Holmes, I. J. Kopin, and Y. Sharabi, Intra-neuronal vesicular uptake of catecholamines is decreased in patients with Lewy body diseases, J Clin Invest, vol.121, pp.3320-3350, 2011.

M. Goodall and A. Thorburn, Identifying specific receptors for cargo-mediated autophagy, Cell Res, vol.24, pp.783-787, 2014.

S. Govind, R. Kozma, C. Monfries, L. Lim, and S. Ahmed, Cdc42Hs facilitates cytoskeletal reorganization and neurite outgrowth by localizing the 58-kD insulin receptor substrate to filamentous actin, J Cell Biol, vol.152, pp.579-94, 2001.

J. G. Graham and D. R. Oppenheimer, Orthostatic hypotension and nicotine sensitivity in a case of multiple system atrophy, J Neurol Neurosurg Psychiatry, vol.32, pp.28-34, 1969.

J. T. Guo, A. Q. Chen, Q. Kong, H. Zhu, C. M. Ma et al., Inhibition of vesicular monoamine transporter-2 activity in alpha-synuclein stably transfected SH-SY5Y cells, Cell Mol Neurobiol, vol.28, pp.35-47, 2008.

S. Hall, A. Ohrfelt, R. Constantinescu, U. Andreasson, Y. Surova et al., Accuracy of a panel of 5 cerebrospinal fluid biomarkers in the differential diagnosis of patients with dementia and/or parkinsonian disorders, Arch Neurol, vol.69, pp.1445-52, 2012.

O. Hansson, S. Janelidze, S. Hall, N. Magdalinou, A. J. Lees et al., Blood-based NfL: A biomarker for differential diagnosis of parkinsonian disorder, Neurology, vol.88, pp.930-937, 2017.

O. Hantschel, Structure, regulation, signaling, and targeting of abl kinases in cancer, Genes Cancer, vol.3, pp.436-482, 2012.

H. Harada, J. S. Andersen, M. Mann, N. Terada, and S. J. Korsmeyer, p70S6 kinase signals cell survival as well as growth, inactivating the pro-apoptotic molecule BAD, Proc Natl Acad Sci U S A, vol.98, pp.9666-70, 2001.

D. E. Harrison, R. Strong, Z. D. Sharp, J. F. Nelson, C. M. Astle et al., Rapamycin fed late in life extends lifespan in genetically heterogeneous mice, Nature, vol.460, pp.392-397, 2009.

L. Hartner, T. W. Keil, M. Kreuzer, E. M. Fritz, G. K. Wenning et al., Distinct Parameters in the EEG of the PLP alpha-SYN Mouse Model for Multiple System Atrophy Reinforce Face Validity, Front Behav Neurosci, vol.10, p.252, 2016.

M. L. Hebron, I. Lonskaya, and C. E. Moussa, Nilotinib reverses loss of dopamine neurons and improves motor behavior via autophagic degradation of alpha-synuclein in Parkinson's disease models, Hum Mol Genet, vol.22, pp.3315-3343, 2013.

S. Z. Imam, Q. Zhou, A. Yamamoto, A. J. Valente, S. F. Ali et al., Novel regulation of parkin function through c-Abl-mediated tyrosine phosphorylation: implications for Parkinson's disease, J Neurosci, vol.31, pp.157-63, 2011.

M. Ingelsson, Alpha-Synuclein Oligomers-Neurotoxic Molecules in Parkinson's Disease and Other Lewy Body Disorders, Front Neurosci, vol.10, p.408, 2016.

M. Inoue, S. Yagishita, M. Ryo, K. Hasegawa, N. Amano et al., The distribution and dynamic density of oligodendroglial cytoplasmic inclusions (GCIs) in multiple system atrophy: a correlation between the density of GCIs and the degree of involvement of striatonigral and olivopontocerebellar systems, Acta Neuropathol, vol.93, pp.585-91, 1997.

K. Ishizawa, T. Komori, N. Arai, T. Mizutani, and T. Hirose, Glial cytoplasmic inclusions and tissue injury in multiple system atrophy: A quantitative study in white matter (olivopontocerebellar system) and gray matter (nigrostriatal system), Neuropathology, vol.28, pp.249-57, 2008.

K. Ishizawa, T. Komori, S. Sasaki, N. Arai, T. Mizutani et al., Microglial activation parallels system degeneration in multiple system atrophy, J Neuropathol Exp Neurol, vol.63, pp.43-52, 2004.

S. Jakel and L. Dimou, Glial Cells and Their Function in the Adult Brain: A Journey through the History of Their Ablation, Front Cell Neurosci, vol.11, p.24, 2017.

R. Jakes, M. G. Spillantini, and M. Goedert, Identification of two distinct synucleins from human brain, FEBS Lett, vol.345, pp.27-32, 1994.

J. Jankovic, Parkinson's disease: clinical features and diagnosis, J Neurol Neurosurg Psychiatry, vol.79, pp.368-76, 2008.

M. Jecmenica-lukic, W. Poewe, E. Tolosa, and G. K. Wenning, Premotor signs and symptoms of multiple system atrophy, Lancet Neurol, vol.11, pp.361-369, 2012.

H. Jin, K. Ishikawa, T. Tsunemi, T. Ishiguro, T. Amino et al., Analyses of copy number and mRNA expression level of the alpha-synuclein gene in multiple system atrophy, J Med Dent Sci, vol.55, pp.145-53, 2008.

C. H. Jung, S. H. Ro, J. Cao, N. M. Otto, and D. H. Kim, mTOR regulation of autophagy, FEBS Lett, vol.584, pp.1287-95, 2010.

P. J. Kahle, M. Neumann, L. Ozmen, V. Muller, H. Jacobsen et al., Hyperphosphorylation and insolubility of alpha-synuclein in transgenic mouse oligodendrocytes, EMBO Rep, vol.3, pp.583-591, 2002.

S. S. Karuppagounder, S. Brahmachari, Y. Lee, V. L. Dawson, T. M. Dawson et al., The c-Abl inhibitor, nilotinib, protects dopaminergic neurons in a preclinical animal model of Parkinson's disease, 2014.

H. Kaufmann, L. Norcliffe-kaufmann, J. A. Palma, I. Biaggioni, P. A. Low et al., Natural history of pure autonomic failure: A United States prospective cohort, Ann Neurol, vol.81, pp.287-297, 2017.

Y. Kawamoto, Y. Kobayashi, Y. Suzuki, H. Inoue, H. Tomimoto et al., Accumulation of HtrA2/Omi in neuronal and glial inclusions in brains with alpha-synucleinopathies, J Neuropathol Exp Neurol, vol.67, pp.984-93, 2008.

J. Kim, M. Kundu, B. Viollet, and K. L. Guan, AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1, Nat Cell Biol, vol.13, pp.132-173, 2011.

A. Klegeris, S. Pelech, B. I. Giasson, J. Maguire, H. Zhang et al., Alpha-synuclein activates stress signaling protein kinases in THP-1 cells and microglia, Neurobiol Aging, vol.29, pp.739-52, 2008.

D. J. Klionsky, A. J. Meijer, and P. Codogno, Autophagy and p70S6 kinase, Autophagy, vol.1, pp.59-60, 2005.

J. Klucken, A. M. Poehler, D. Ebrahimi-fakhari, J. Schneider, S. Nuber et al., Alpha-synuclein aggregation involves a bafilomycin A 1-sensitive autophagy pathway, Autophagy, vol.8, pp.754-66, 2012.

H. S. Ko, Y. Lee, J. H. Shin, S. S. Karuppagounder, B. S. Gadad et al., Phosphorylation by the c-Abl protein tyrosine kinase inhibits parkin's ubiquitination and protective function, Proc Natl Acad Sci U S A, vol.107, pp.16691-16697, 2010.

M. Kollensperger, F. Geser, J. P. Ndayisaba, S. Boesch, K. Seppi et al., Presentation, diagnosis, and management of multiple system atrophy in Europe, Mov Disord, vol.25, pp.2604-2616, 2010.

J. H. Kordower, Y. Chu, R. A. Hauser, T. B. Freeman, and C. W. Olanow, Lewy body-like pathology in long-term embryonic nigral transplants in Parkinson's disease, Nat Med, vol.14, pp.504-510, 2008.

C. L. Kragh, G. Fillon, A. Gysbers, H. D. Hansen, M. Neumann et al., FAS-dependent cell death in alpha-synuclein transgenic oligodendrocyte models of multiple system atrophy, PLoS One, vol.8, p.55243, 2013.

P. H. Kraus, M. R. Lemke, and H. Reichmann, Kinetic tremor in Parkinson's disease--an underrated symptom, J Neural Transm, vol.113, pp.845-53, 2006.

F. Krismer and G. K. Wenning, Multiple system atrophy: insights into a rare and debilitating movement disorder, Nat Rev Neurol, vol.13, pp.232-243, 2017.

D. Kuzdas-wood, N. Stefanova, K. A. Jellinger, K. Seppi, M. G. Schlossmacher et al., Towards translational therapies for multiple system atrophy, Prog Neurobiol, vol.118, pp.19-35, 2014.

D. Kuzdas, S. Stemberger, S. Gaburro, N. Stefanova, N. Singewald et al., Oligodendroglial alpha-synucleinopathy and MSA-like cardiovascular autonomic failure: experimental evidence, Exp Neurol, vol.247, pp.531-537, 2013.

H. A. Lashuel, C. R. Overk, A. Oueslati, and E. Masliah, The many faces of alpha-synuclein: from structure and toxicity to therapeutic target, Nat Rev Neurosci, vol.14, pp.38-48, 2013.

B. Laurens, R. Constantinescu, R. Freeman, A. Gerhard, K. Jellinger et al., Fluid biomarkers in multiple system atrophy: A review of the MSA Biomarker Initiative, vol.80, pp.29-41, 2015.

H. J. Lee, S. Patel, and S. J. Lee, Intravesicular localization and exocytosis of alpha-synuclein and its aggregates, J Neurosci, vol.25, pp.6016-6040, 2005.

H. J. Lee, J. E. Suk, E. J. Bae, J. H. Lee, S. R. Paik et al., Assembly-dependent endocytosis and clearance of extracellular alpha-synuclein, Int J Biochem Cell Biol, vol.40, pp.1835-1884, 2008.

H. J. Lee, J. E. Suk, C. Patrick, E. J. Bae, J. H. Cho et al., Direct transfer of alpha-synuclein from neuron to astroglia causes inflammatory responses in synucleinopathies, J Biol Chem, vol.285, pp.9262-72, 2010.

S. J. Lee, P. Desplats, H. J. Lee, B. Spencer, and E. Masliah, Cell-to-cell transmission of alphasynuclein aggregates, Methods Mol Biol, vol.849, pp.347-59, 2012.

J. Y. Li, E. Englund, J. L. Holton, D. Soulet, P. Hagell et al., Lewy bodies in grafted neurons in subjects with Parkinson's disease suggest host-to-graft disease propagation, Nat Med, vol.14, pp.501-504, 2008.

H. Ling, Y. T. Asi, I. N. Petrovic, Z. Ahmed, L. K. Prashanth et al., Minimal change multiple system atrophy: an aggressive variant, vol.30, pp.960-967, 2015.

I. Lonskaya, N. M. Desforges, M. L. Hebron, and C. E. Moussa, Ubiquitination increases parkin activity to promote autophagic alpha-synuclein clearance, PLoS One, vol.8, p.83914, 2013.

S. Maass, J. Levin, and G. Hoglinger, Current Treatment of Multiple System Atrophy, Curr Treat Options Neurol, vol.18, p.51, 2016.

J. Madine, A. J. Doig, and D. A. Middleton, A study of the regional effects of alpha-synuclein on the organization and stability of phospholipid bilayers, Biochemistry, vol.45, pp.5783-92, 2006.

F. Magrinelli, A. Picelli, P. Tocco, A. Federico, L. Roncari et al., Pathophysiology of Motor Dysfunction in Parkinson's Disease as the Rationale for Drug Treatment and Rehabilitation, Parkinsons Dis, p.9832839, 2016.

A. L. Mahul-mellier, B. Fauvet, A. Gysbers, I. Dikiy, A. Oueslati et al., c-Abl phosphorylates alpha-synuclein and regulates its degradation: implication for alpha-synuclein clearance and contribution to the pathogenesis of Parkinson's disease, Hum Mol Genet, vol.23, pp.2858-79, 2014.

P. Mailankody, M. Netravathi, and P. K. Pal, Review of tremor in Parkinson's disease and atypical parkinsonian disorders, Neurol India, vol.65, pp.1083-1090, 2017.

C. Malagelada, Z. H. Jin, V. Jackson-lewis, S. Przedborski, and L. A. Greene, Rapamycin protects against neuron death in in vitro and in vivo models of Parkinson's disease, J Neurosci, vol.30, pp.1166-75, 2010.

H. Y. Man, J. W. Lin, W. H. Ju, G. Ahmadian, L. Liu et al., Regulation of AMPA receptor-mediated synaptic transmission by clathrin-dependent receptor internalization, Neuron, vol.25, pp.649-62, 2000.

R. J. Mandel, D. J. Marmion, D. Kirik, Y. Chu, C. Heindel et al., Novel oligodendroglial alpha synuclein viral vector models of multiple system atrophy: studies in rodents and nonhuman primates, Acta Neuropathol Commun, vol.5, p.47, 2017.

D. R. Marks, K. Tucker, M. A. Cavallin, T. G. Mast, and D. A. Fadool, Awake intranasal insulin delivery modifies protein complexes and alters memory, anxiety, and olfactory behaviors, J Neurosci, vol.29, pp.6734-51, 2009.

M. J. Marti, E. Tolosa, and J. Campdelacreu, Clinical overview of the synucleinopathies, Mov Disord, issue.6, pp.21-28, 2003.

C. J. Mathias, Gastrointestinal dysfunction in multiple system atrophy, Semin Neurol, vol.16, pp.251-259, 1996.

A. Matsuo, I. Akiguchi, G. C. Lee, E. G. Mcgeer, P. L. Mcgeer et al., Myelin degeneration in multiple system atrophy detected by unique antibodies, Am J Pathol, vol.153, pp.735-779, 1998.

V. E. May, B. Ettle, A. M. Poehler, S. Nuber, K. Ubhi et al., alpha-Synuclein impairs oligodendrocyte progenitor maturation in multiple system atrophy, Neurobiol Aging, vol.35, pp.2357-68, 2014.

F. Mayor, . Jr, M. Cruces-sande, A. C. Arcones, R. Vila-bedmar et al., G protein-coupled receptor kinase 2 (GRK2) as an integrative signalling node in the regulation of cardiovascular function and metabolic homeostasis, Cell Signal, vol.41, pp.25-32, 2018.

F. Mayor, . Jr, E. Lucas, M. Jurado-pueyo, L. Garcia-guerra et al., Protein-coupled receptor kinase 2 (GRK2): A novel modulator of insulin resistance, Arch Physiol Biochem, vol.117, pp.125-155, 2011.

H. Mccann, C. H. Stevens, H. Cartwright, and G. M. Halliday, Parkinsonism Relat Disord, issue.1, pp.62-69, 1920.

J. H. Mckay and W. P. Cheshire, First symptoms in multiple system atrophy, Clin Auton Res, vol.28, pp.215-221, 2018.

W. G. Meissner, O. Flabeau, P. Perez, J. Taillard, F. Marquant et al., Accuracy of portable polygraphy for the diagnosis of sleep apnea in multiple system atrophy, Sleep Med, vol.15, pp.476-485, 2014.

J. G. Mielke, C. Taghibiglou, and Y. T. Wang, Endogenous insulin signaling protects cultured neurons from oxygen-glucose deprivation-induced cell death, Neuroscience, vol.143, pp.165-73, 2006.

Y. Miki, K. Tanji, F. Mori, Y. Tatara, J. Utsumi et al., AMBRA1, a novel alpha-synuclein-binding protein, is implicated in the pathogenesis of multiple system atrophy, Brain Pathol, vol.28, pp.28-42, 2018.

D. W. Miller, J. M. Johnson, S. M. Solano, Z. R. Hollingsworth, D. G. Standaert et al., Absence of alpha-synuclein mRNA expression in normal and multiple system atrophy oligodendroglia, J Neural Transm, vol.112, pp.1613-1637, 2005.

N. Mizushima and T. Yoshimori, How to interpret LC3 immunoblotting, Autophagy, vol.3, pp.542-547, 2007.

B. Mollenhauer, J. J. Locascio, W. Schulz-schaeffer, F. Sixel-doring, C. Trenkwalder et al., alpha-Synuclein and tau concentrations in cerebrospinal fluid of patients presenting with parkinsonism: a cohort study, Lancet Neurol, vol.10, pp.230-270, 2011.

A. M. Moloney, R. J. Griffin, S. Timmons, R. O'connor, R. Ravid et al., Defects in IGF-1 receptor, insulin receptor and IRS-1/2 in Alzheimer's disease indicate possible resistance to IGF-1 and insulin signalling, Neurobiol Aging, vol.31, pp.224-267, 2010.

S. Mondello, R. Constantinescu, H. Zetterberg, U. Andreasson, B. Holmberg et al., CSF alpha-synuclein and UCH-L1 levels in Parkinson's disease and atypical parkinsonian disorders, Parkinsonism Relat Disord, vol.20, pp.382-389, 2014.

S. Moussaud, D. R. Jones, E. L. Moussaud-lamodiere, M. Delenclos, O. A. Ross et al., Alpha-synuclein and tau: teammates in neurodegeneration?, Mol Neurodegener, vol.9, p.43, 2014.

M. Nishie, F. Mori, M. Yoshimoto, H. Takahashi, and K. Wakabayashi, A quantitative investigation of neuronal cytoplasmic and intranuclear inclusions in the pontine and inferior olivary nuclei in multiple system atrophy, Neuropathol Appl Neurobiol, vol.30, pp.546-54, 2004.

W. H. Oertel, T. Wachter, N. P. Quinn, G. Ulm, and D. Brandstadter, Reduced genital sensitivity in female patients with multiple system atrophy of parkinsonian type, Mov Disord, vol.18, pp.430-432, 2003.

K. Ota, M. Obayashi, K. Ozaki, S. Ichinose, A. Kakita et al., Relocation of p25alpha/tubulin polymerization promoting protein from the nucleus to the perinuclear cytoplasm in the oligodendroglia of sporadic and COQ2 mutant multiple system atrophy, Acta Neuropathol Commun, vol.2, p.136, 2014.

T. Ozawa, K. Okuizumi, T. Ikeuchi, K. Wakabayashi, H. Takahashi et al., Analysis of the expression level of alpha-synuclein mRNA using postmortem brain samples from pathologically confirmed cases of multiple system atrophy, Acta Neuropathol, vol.102, pp.188-90, 2001.

T. Ozawa, K. Oyanagi, H. Tanaka, Y. Horikawa, H. Takahashi et al., Suprachiasmatic nucleus in a patient with multiple system atrophy with abnormal circadian rhythm of arginine-vasopressin secretion into plasma, J Neurol Sci, vol.154, pp.116-137, 1998.

T. Ozawa, D. Paviour, N. P. Quinn, K. A. Josephs, H. Sangha et al., The spectrum of pathological involvement of the striatonigral and olivopontocerebellar systems in multiple system atrophy: clinicopathological correlations, Brain, vol.127, pp.2657-71, 2004.

T. Ozawa, K. Sekiya, N. Aizawa, K. Terajima, and M. Nishizawa, Laryngeal stridor in multiple system atrophy: Clinicopathological features and causal hypotheses, J Neurol Sci, vol.361, pp.243-252, 2016.

F. Pagan, M. Hebron, E. H. Valadez, Y. Torres-yaghi, X. Huang et al., Nilotinib Effects in Parkinson's disease and Dementia with Lewy bodies, J Parkinsons Dis, vol.6, pp.503-520, 2016.

J. A. Palma, L. Norcliffe-kaufmann, and H. Kaufmann, Diagnosis of multiple system atrophy, Auton Neurosci, vol.211, pp.15-25, 2018.

M. I. Papp, J. E. Kahn, and P. L. Lantos, Glial cytoplasmic inclusions in the CNS of patients with multiple system atrophy (striatonigral degeneration, olivopontocerebellar atrophy and Shy-Drager syndrome), J Neurol Sci, vol.94, pp.79-100, 1989.

J. Y. Park, S. R. Paik, I. Jou, and S. M. Park, Microglial phagocytosis is enhanced by monomeric alpha-synuclein, not aggregated alpha-synuclein: implications for Parkinson's disease, Glia, vol.56, pp.1215-1238, 2008.

M. T. Pellecchia, R. Pivonello, K. Longo, M. Manfredi, A. Tessitore et al., Multiple system atrophy is associated with changes in peripheral insulin-like growth factor system, Mov Disord, vol.25, pp.2621-2627, 2010.

R. G. Perez, J. C. Waymire, E. Lin, J. J. Liu, F. Guo et al., A role for alphasynuclein in the regulation of dopamine biosynthesis, J Neurosci, vol.22, pp.3090-3099, 2002.

A. Petzold, E. J. Thompson, G. Keir, N. Quinn, B. Holmberg et al., Longitudinal one-year study of levels and stoichiometry of neurofilament heavy and light chain concentrations in CSF in patients with multiple system atrophy, J Neurol Sci, vol.279, pp.76-85, 2009.

M. H. Polymeropoulos, C. Lavedan, E. Leroy, S. E. Ide, A. Dehejia et al., Mutation in the alpha-synuclein gene identified in families with Parkinson's disease, Science, vol.276, pp.2045-2052, 1997.

D. L. Pountney, F. Chegini, X. Shen, P. C. Blumbergs, and W. P. Gai, SUMO-1 marks subdomains within glial cytoplasmic inclusions of multiple system atrophy, Neurosci Lett, vol.381, pp.74-83, 2005.

R. T. Premont and R. R. Gainetdinov, Physiological roles of G protein-coupled receptor kinases and arrestins, Annu Rev Physiol, vol.69, pp.511-545, 2007.

S. Probst-cousin, M. Bergmann, K. Kuchelmeister, R. Schroder, and K. W. Schmid, Ubiquitin-positive inclusions in different types of multiple system atrophy: distribution and specificity, Pathol Res Pract, vol.192, pp.453-61, 1996.

S. Probst-cousin, C. H. Rickert, K. W. Schmid, and F. Gullotta, Cell death mechanisms in multiple system atrophy, J Neuropathol Exp Neurol, vol.57, pp.814-835, 1998.

R. Puertollano, mTOR and lysosome regulation, 1000.

N. Quinn, A short clinical history of multiple system atrophy, Clin Auton Res, vol.25, pp.3-7, 2015.

R. Radford, A. Rcom-h'cheo-gauthier, M. B. Wong, E. D. Eaton, M. Quilty et al., The degree of astrocyte activation in multiple system atrophy is inversely proportional to the distance to alpha-synuclein inclusions, Mol Cell Neurosci, vol.65, pp.68-81, 2015.

S. Randall-demllo, M. Chieppa, and R. Eri, Intestinal epithelium and autophagy: partners in gut homeostasis, Front Immunol, vol.4, p.301, 2013.

P. Redgrave, M. Rodriguez, Y. Smith, M. C. Rodriguez-oroz, S. Lehericy et al., Goal-directed and habitual control in the basal ganglia: implications for Parkinson's disease, Nat Rev Neurosci, vol.11, pp.760-72, 2010.

V. Refolo, F. Bez, A. Polissidis, D. Kuzdas-wood, E. Sturm et al., Progressive striatonigral degeneration in a transgenic mouse model of multiple system atrophy: translational implications for interventional therapies, Acta Neuropathol Commun, vol.6, issue.2, 2018.

G. Rengo, G. Pagano, S. Paolillo, C. De-lucia, G. D. Femminella et al., Impact of diabetes mellitus on lymphocyte GRK2 protein levels in patients with heart failure, Eur J Clin Invest, vol.45, pp.187-95, 2015.

J. F. Reyes, N. L. Rey, L. Bousset, R. Melki, P. Brundin et al., Alpha-synuclein transfers from neurons to oligodendrocytes, Glia, vol.62, pp.387-98, 2014.
URL : https://hal.archives-ouvertes.fr/hal-01181201

A. D. Reynolds, J. G. Glanzer, I. Kadiu, M. Ricardo-dukelow, A. Chaudhuri et al., Nitrated alpha-synuclein-activated microglial profiling for Parkinson's disease, J Neurochem, vol.104, pp.1504-1529, 2008.

H. J. Rideout and L. Stefanis, Proteasomal inhibition-induced inclusion formation and death in cortical neurons require transcription and ubiquitination, Mol Cell Neurosci, vol.21, pp.223-261, 2002.

D. Roncevic, J. A. Palma, J. Martinez, N. Goulding, L. Norcliffe-kaufmann et al., Cerebellar and parkinsonian phenotypes in multiple system atrophy: similarities, differences and survival, J Neural Transm, vol.121, pp.507-519, 2014.

A. Sakurai, K. Okamoto, M. Yaguchi, Y. Fujita, Y. Mizuno et al., Pathology of the inferior olivary nucleus in patients with multiple system atrophy, Acta Neuropathol, vol.103, pp.550-554, 2002.

K. Sakushima, N. Nishimoto, M. Nojima, M. Matsushima, I. Yabe et al., Epidemiology of Multiple System Atrophy in Hokkaido, the Northernmost Island of Japan, Cerebellum, vol.14, pp.682-689, 2015.

P. Salomoni and B. Calabretta, Targeted therapies and autophagy: new insights from chronic myeloid leukemia, Autophagy, vol.5, pp.1050-1051, 2009.

E. Santini, M. Heiman, P. Greengard, E. Valjent, G. Fisone et al., Mesopontine cholinergic neuron involvement in Lewy body dementia and multiple system atrophy, Sci Signal, vol.2, pp.368-73, 2008.

A. Schrag, Y. Ben-shlomo, and N. P. Quinn, Prevalence of progressive supranuclear palsy and multiple system atrophy: a cross-sectional study, Lancet, vol.354, pp.1771-1776, 1999.

M. W. Schwartz, R. N. Bergman, S. E. Kahn, G. J. Taborsky, J. R. Fisher et al., Evidence for entry of plasma insulin into cerebrospinal fluid through an intermediate compartment in dogs. Quantitative aspects and implications for transport, J Clin Invest, vol.88, pp.1272-81, 1991.

L. Schwarz, O. Goldbaum, M. Bergmann, S. Probst-cousin, and C. Richter-landsberg, Involvement of macroautophagy in multiple system atrophy and protein aggregate formation in oligodendrocytes, J Mol Neurosci, vol.47, pp.256-66, 2012.

M. E. Shaker, A. Ghani, G. E. Shiha, T. M. Ibrahim, and W. Z. Mehal, Nilotinib induces apoptosis and autophagic cell death of activated hepatic stellate cells via inhibition of histone deacetylases, Biochim Biophys Acta, vol.1833, 1992.

Z. Sheng, L. Ma, J. E. Sun, L. J. Zhu, and M. R. Green, BCR-ABL suppresses autophagy through ATF5-mediated regulation of mTOR transcription, Blood, vol.118, pp.2840-2848, 2011.

M. Shimobayashi and M. N. Hall, Making new contacts: the mTOR network in metabolism and signalling crosstalk, Nat Rev Mol Cell Biol, vol.15, pp.155-62, 2014.

G. M. Shy and G. A. Drager, A neurological syndrome associated with orthostatic hypotension: a clinical-pathologic study, Arch Neurol, vol.2, pp.511-538, 1960.

M. Simons and K. A. Nave, Oligodendrocytes: Myelination and Axonal Support, Cold Spring Harb Perspect Biol, vol.8, p.20479, 2015.

Y. J. Song, D. M. Lundvig, Y. Huang, W. P. Gai, P. C. Blumbergs et al., p25alpha relocalizes in oligodendroglia from myelin to cytoplasmic inclusions in multiple system atrophy, Am J Pathol, vol.171, pp.1291-303, 2007.

M. G. Spillantini, R. A. Crowther, R. Jakes, N. J. Cairns, P. L. Lantos et al., Filamentous alpha-synuclein inclusions link multiple system atrophy with Parkinson's disease and dementia with Lewy bodies, Neurosci Lett, vol.251, pp.205-213, 1998.

M. G. Spillantini, R. A. Crowther, R. Jakes, M. Hasegawa, and M. Goedert, alpha-Synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with lewy bodies, Proc Natl Acad Sci U S A, vol.95, pp.6469-73, 1998.

M. G. Spillantini, A. Divane, and M. Goedert, Assignment of human alpha-synuclein (SNCA) and beta-synuclein (SNCB) genes to chromosomes 4q21 and 5q35, Genomics, vol.27, pp.379-81, 1995.

M. G. Spillantini, M. L. Schmidt, V. M. Lee, J. Q. Trojanowski, R. Jakes et al., Alpha-synuclein in Lewy bodies, Nature, vol.388, pp.839-879, 1997.

I. Stankovic, F. Krismer, A. Jesic, A. Antonini, T. Benke et al., Cognitive impairment in multiple system atrophy: a position statement by the Neuropsychology Task Force of the MDS Multiple System Atrophy (MODIMSA) study group, vol.29, pp.857-67, 2014.

N. Stefanova, M. Reindl, M. Neumann, P. J. Kahle, W. Poewe et al., Microglial activation mediates neurodegeneration related to oligodendroglial alphasynucleinopathy: implications for multiple system atrophy, Mov Disord, vol.22, pp.2196-203, 2007.

N. Stefanova and G. K. Wenning, Animal models of multiple system atrophy, Clin Auton Res, vol.25, pp.9-17, 2015.

N. Stefanova and G. K. Wenning, Review: Multiple system atrophy: emerging targets for interventional therapies, Neuropathol Appl Neurobiol, vol.42, pp.20-32, 2016.

S. Stemberger, W. Poewe, G. K. Wenning, and N. Stefanova, Targeted overexpression of human alpha-synuclein in oligodendroglia induces lesions linked to MSA-like progressive autonomic failure, Exp Neurol, vol.224, pp.459-64, 2010.

A. Stolz, A. Ernst, and I. Dikic, Cargo recognition and trafficking in selective autophagy, Nat Cell Biol, vol.16, pp.495-501, 2014.

X. Su, K. A. Maguire-zeiss, R. Giuliano, L. Prifti, K. Venkatesh et al., Synuclein activates microglia in a model of Parkinson's disease, Neurobiol Aging, vol.29, pp.1690-701, 2008.

J. Swant, J. S. Goodwin, A. North, A. A. Ali, J. Gamble-george et al., alpha-Synuclein stimulates a dopamine transporter-dependent chloride current and modulates the activity of the transporter, J Biol Chem, vol.286, pp.43933-43976, 2011.

Y. N. Sylvie-delcambre and . Karsten-hiller, Dopamine metabolism and reactive oxygen species production, Mitochondrial Mechanisms of Degeneration and Repair in Parkinson's Disease, 2016.

K. Taguchi, T. Matsumoto, K. Kamata, and T. Kobayashi, G protein-coupled receptor kinase 2, with beta-arrestin 2, impairs insulin-induced Akt/endothelial nitric oxide synthase signaling in ob/ob mouse aorta, Diabetes, vol.61, pp.1978-85, 2012.

M. Tanaka, Y. M. Kim, G. Lee, E. Junn, T. Iwatsubo et al., Aggresomes formed by alpha-synuclein and synphilin-1 are cytoprotective, J Biol Chem, vol.279, pp.4625-4656, 2004.

Y. Tanaka, T. Kato, H. Nishida, M. Yamada, A. Koumura et al., Is there delayed gastric emptying in patients with multiple system atrophy? An analysis using the (13)C-acetate breath test, J Neurol, vol.259, pp.1448-52, 2012.

S. A. Tanik, C. E. Schultheiss, L. A. Volpicelli-daley, K. R. Brunden, and V. M. Lee, Lewy body-like alpha-synuclein aggregates resist degradation and impair macroautophagy, J Biol Chem, vol.288, pp.15194-210, 2013.

K. Tanji, S. Odagiri, A. Maruyama, F. Mori, A. Kakita et al., Alteration of autophagosomal proteins in the brain of multiple system atrophy, Neurobiol Dis, vol.49, pp.190-198, 2013.

S. Theodore, S. Cao, P. J. Mclean, and D. G. Standaert, Targeted overexpression of human alpha-synuclein triggers microglial activation and an adaptive immune response in a mouse model of Parkinson disease, J Neuropathol Exp Neurol, vol.67, pp.1149-58, 2008.

F. Tison, F. Yekhlef, V. Chrysostome, E. Balestre, N. P. Quinn et al., Parkinsonism in multiple system atrophy: natural history, severity (UPDRS-III), and disability assessment compared with Parkinson's disease, vol.17, pp.701-710, 2002.

J. Tong, H. Wong, M. Guttman, L. C. Ang, L. S. Forno et al., Brain alphasynuclein accumulation in multiple system atrophy, Parkinson's disease and progressive supranuclear palsy: a comparative investigation, Brain, vol.133, pp.172-88, 2010.

Y. Tu, C. Chen, J. Pan, J. Xu, Z. G. Zhou et al., The Ubiquitin Proteasome Pathway (UPP) in the regulation of cell cycle control and DNA damage repair and its implication in tumorigenesis, Int J Clin Exp Pathol, vol.5, pp.726-764, 2012.

K. Ubhi, E. Rockenstein, M. Mante, C. Inglis, A. Adame et al., Neurodegeneration in a transgenic mouse model of multiple system atrophy is associated with altered expression of oligodendroglial-derived neurotrophic factors, J Neurosci, vol.30, pp.6236-6282, 2010.

K. Ueda, H. Fukushima, E. Masliah, Y. Xia, A. Iwai et al., Molecular cloning of cDNA encoding an unrecognized component of amyloid in Alzheimer disease, Proc Natl Acad Sci U S A, vol.90, pp.11282-11288, 1993.

I. Usui, T. Imamura, H. Satoh, J. Huang, J. L. Babendure et al., GRK2 is an endogenous protein inhibitor of the insulin signaling pathway for glucose transport stimulation, EMBO J, vol.23, pp.2821-2830, 2004.

E. Valera and E. Masliah, The neuropathology of multiple system atrophy and its therapeutic implications, Auton Neurosci, vol.211, pp.1-6, 2018.

E. Valera, B. Spencer, J. Mott, M. Trejo, A. Adame et al., MicroRNA-101 Modulates Autophagy and Oligodendroglial Alpha-Synuclein Accumulation in Multiple System Atrophy, Front Mol Neurosci, vol.10, p.329, 2017.

E. Valera, K. Ubhi, M. Mante, E. Rockenstein, and E. Masliah, Antidepressants reduce neuroinflammatory responses and astroglial alpha-synuclein accumulation in a transgenic mouse model of multiple system atrophy, Glia, vol.62, pp.317-354, 2014.

A. Van-der-perren, . Van-den, C. Haute, and V. Baekelandt, Viral vector-based models of Parkinson's disease, Curr Top Behav Neurosci, vol.22, pp.271-301, 2015.

J. Varkey, J. M. Isas, N. Mizuno, M. B. Jensen, V. K. Bhatia et al., Membrane curvature induction and tubulation are common features of synucleins and apolipoproteins, J Biol Chem, vol.285, pp.32486-93, 2010.

R. Vila-bedmar, M. Cruces-sande, E. Lucas, H. L. Willemen, C. J. Heijnen et al., Reversal of diet-induced obesity and insulin resistance by inducible genetic ablation of GRK2, Sci Signal, vol.8, p.73, 2015.

T. Vogiatzi, M. Xilouri, K. Vekrellis, and L. Stefanis, Wild type alpha-synuclein is degraded by chaperone-mediated autophagy and macroautophagy in neuronal cells, J Biol Chem, vol.283, pp.23542-56, 2008.

L. A. Volpicelli-daley, K. C. Luk, T. P. Patel, S. A. Tanik, D. M. Riddle et al., Exogenous alpha-synuclein fibrils induce Lewy body pathology leading to synaptic dysfunction and neuron death, Neuron, vol.72, pp.57-71, 2011.

G. Von-jonquieres, N. Mersmann, C. B. Klugmann, A. E. Harasta, B. Lutz et al., Glial promoter selectivity following AAV-delivery to the immature brain, PLoS One, vol.8, p.65646, 2013.

D. M. Walsh and D. J. Selkoe, A critical appraisal of the pathogenic protein spread hypothesis of neurodegeneration, Nat Rev Neurosci, vol.17, pp.251-60, 2016.

G. F. Wang, C. Li, and G. J. Pielak, 19F NMR studies of alpha-synuclein-membrane interactions, Protein Sci, vol.19, pp.1686-91, 2010.

H. Watanabe, Y. Saito, S. Terao, T. Ando, T. Kachi et al., Progression and prognosis in multiple system atrophy: an analysis of 230 Japanese patients, Brain, vol.125, pp.1070-83, 2002.

J. L. Webb, B. Ravikumar, J. Atkins, J. N. Skepper, and D. C. Rubinsztein, Alpha-Synuclein is degraded by both autophagy and the proteasome, J Biol Chem, vol.278, pp.25009-25022, 2003.

Q. Wei, W. K. Miskimins, and R. Miskimins, Cloning and characterization of the rat myelin basic protein gene promoter, Gene, vol.313, pp.161-168, 2003.

G. K. Wenning, Y. Ben-shlomo, M. Magalhaes, S. E. Daniel, and N. P. Quinn, Clinicopathological study of 35 cases of multiple system atrophy, J Neurol Neurosurg Psychiatry, vol.58, pp.160-166, 1995.

G. K. Wenning, F. Geser, F. Krismer, K. Seppi, S. Duerr et al., The natural history of multiple system atrophy: a prospective European cohort study, vol.12, pp.264-74, 2013.

G. K. Wenning, R. Granata, F. Krismer, S. Durr, K. Seppi et al., Orthostatic hypotension is differentially associated with the cerebellar versus the parkinsonian variant of multiple system atrophy: a comparative study, Cerebellum, vol.11, pp.223-229, 2012.

G. K. Wenning, K. Seppi, F. Tison, and K. Jellinger, A novel grading scale for striatonigral degeneration (multiple system atrophy), J Neural Transm, vol.109, pp.307-327, 2002.

G. K. Wenning, N. Stefanova, K. A. Jellinger, W. Poewe, and M. G. Schlossmacher, Multiple system atrophy: a primary oligodendrogliopathy, Ann Neurol, vol.64, pp.239-285, 2008.

G. K. Wenning, F. Tison, K. Seppi, C. Sampaio, A. Diem et al., Development and validation of the Unified Multiple System Atrophy Rating Scale (UMSARS), Mov Disord, vol.19, pp.1391-402, 2004.

C. Wersinger, M. Rusnak, and A. Sidhu, Modulation of the trafficking of the human serotonin transporter by human alpha-synuclein, Eur J Neurosci, vol.24, pp.55-64, 2006.

C. Wilke, F. Bender, S. N. Hayer, K. Brockmann, L. Schols et al., Serum neurofilament light is increased in multiple system atrophy of cerebellar type and in repeat-expansion spinocerebellar ataxias: a pilot study, J Neurol, vol.265, pp.1618-1624, 2018.

B. Winner, R. Jappelli, S. K. Maji, P. A. Desplats, L. Boyer et al., In vivo demonstration that alpha-synuclein oligomers are toxic, Proc Natl Acad Sci U S A, vol.108, pp.4194-4203, 2011.

A. R. Winslow, C. W. Chen, S. Corrochano, A. Acevedo-arozena, D. E. Gordon et al., alpha-Synuclein impairs macroautophagy: implications for Parkinson's disease, J Cell Biol, vol.190, pp.1023-1060, 2010.

A. R. Winslow and D. C. Rubinsztein, The Parkinson disease protein alpha-synuclein inhibits autophagy, Autophagy, vol.7, pp.429-460, 2011.

Y. Winter, Y. Bezdolnyy, E. Katunina, G. Avakjan, J. P. Reese et al., Incidence of Parkinson's disease and atypical parkinsonism: Russian population-based study, Mov Disord, vol.25, pp.349-56, 2010.

R. K. Wyse, P. Brundin, and T. B. Sherer, Nilotinib -Differentiating the Hope from the Hype, J Parkinsons Dis, vol.6, pp.519-541, 2016.

M. Xilouri, O. R. Brekk, and L. Stefanis, Autophagy and Alpha-Synuclein: Relevance to Parkinson's Disease and Related Synucleopathies, Mov Disord, vol.31, pp.178-92, 2016.

W. Yang and S. Yu, Synucleinopathies: common features and hippocampal manifestations, Cell Mol Life Sci, vol.74, pp.1485-1501, 2017.

T. Yokoyama, J. I. Kusunoki, K. Hasegawa, H. Sakai, and S. Yagishita, Distribution and dynamic process of neuronal cytoplasmic inclusion (NCI) in MSA: correlation of the density of NCI and the degree of involvement of the pontine nuclei, Neuropathology, vol.21, pp.145-54, 2001.

M. S. Yoon, The Role of Mammalian Target of Rapamycin (mTOR) in Insulin Signaling, Nutrients, p.9, 2017.

H. C. Yu, C. S. Lin, W. T. Tai, C. Y. Liu, C. W. Shiau et al., Nilotinib induces autophagy in hepatocellular carcinoma through AMPK activation, J Biol Chem, vol.288, pp.18249-59, 2013.

M. Zaltieri, J. Grigoletto, F. Longhena, L. Navarria, G. Favero et al., alpha-synuclein and synapsin III cooperatively regulate synaptic function in dopamine neurons, J Cell Sci, vol.128, pp.2231-2274, 2015.

L. Zhang, B. Cao, R. Ou, Q. Q. Wei, B. Zhao et al., Non-motor symptoms and the quality of life in multiple system atrophy with different subtypes, Parkinsonism Relat Disord, vol.35, pp.63-68, 2017.

L. Zhang, B. Cao, Y. Zou, Q. Q. Wei, R. Ou et al., Causes of Death in Chinese Patients with Multiple System Atrophy, Aging Dis, vol.9, pp.102-108, 2018.

W. Zhang, T. Wang, Z. Pei, D. S. Miller, X. Wu et al., Aggregated alpha-synuclein activates microglia: a process leading to disease progression in Parkinson's disease, FASEB J, vol.19, pp.533-575, 2005.